Skip to main content
. 2022 Sep 5;83(5):1059–1070. doi: 10.3348/jksr.2022.0004

Table 2. Demographics of the Study Population.

Parameter All CSC (n = 72) Non-CSC (n = 16)
Mean PSA, ng/mL [range] 21.5283 [0.02–149] 24.5603 [0.85–149] 7.8841 [0.02–20.4]
Tumor location, n (%)
Peripheral zone 44 (50) 33 (46) 11 (69)
Transitional zone 25 (28) 20 (28) 5 (31)
Fibromuscular zone 4 (5) 4 (6) 0 (0)
Diffuse 15 (17) 15 (21) 0 (0)

CSC = clinically significant cancer (Gleason score ≥ 7), PSA = prostate-specific antigen